Australian digital health company Adherium (ASX:ADR) has reported striking interim results from a large-scale US study showing its Hailie Smartinhaler can transform outcomes for people living with chronic respiratory conditions such as asthma and COPD. …
Adherium’s Smartinhaler shows breakthrough results in real-world respiratory study
September 15, 2025 Australian Biotech
Latest Video
Georgia Forrest
New Stories
-
There is no negotiation, yet, so be careful not to give the impression of conceding anything
February 11, 2026 - - Latest News -
Arrotex and Pfizer forge strategic pharmacy partnership for ENBREL in Australia
February 11, 2026 - - Latest News -
Amplia expands U.S. footprint as AMPLICITY pancreatic cancer trial gains momentum
February 11, 2026 - - Australian Biotech -
Canine osteoarthritis study offers compelling translational evidence for PPS
February 11, 2026 - - Australian Biotech -
CSL presses ahead with transformation as earnings slip and leadership changes
February 11, 2026 - - Latest News -
This might be the real once-in-a-generation opportunity achieve reform
February 11, 2026 - - Latest News -
CSL confirms leadership transition as Gordon Naylor steps in as interim CEO
February 10, 2026 - - Latest News